deepapaikar/SC_Katz_5k huggingface dataset:
Benefits Receive industry mentorship Showcase and publish your research at Katz School annual Symposium on Science Technology and Health Receive a scholarship reducing total tuition to K for your entire graduate degree start to finish whether you complete your degree in one or two years about the Fellows Program
Robust forecasting optimization and stochastic system design and their applications to supply chain management Giloni is an associate dean and associate professor of operations management and statistics at the Sy Syms School of Business
After completing the bachelor students can finish the graduate degree in just one more year
He is the co author of articles Neo Rawlsian Fringes A New Approach to Market Segmentation and New Product Development Mathematical Programming Approach for Improving the Robustness of LAD Regression Robust Weighted LAD Regression Robust Analysis of Variance Process Design and Quality Improvement and Information Sharing in a Supply Chain Under ARMA Demand
Students can begin taking graduate courses in their senior year
He holds a Ph D in statistics and operations research from the Leonard Stern School of Business at New York University
The program also offers several opportunities for Curricular Practical Training CPT
Biotech Fellows Join students and alumni from over countries to work on pioneering research citywide initiatives and new technologies that help to make the world smarter safer and healthier
Â 
B A M Pathways Option Through the B A M program undergraduates from Yeshiva College and Stern College for Women can take up to nine graduate credits that count toward both the bachelor and master degrees
As part of his job he oversaw the technical implementation of PASSPort Release the replacement for VENDEX the city vendor portal for vetting and preparing to do business with the city PASSPort Release the replacement of the city purchasing system and the centralized creation of a citywide invoicing system and Release the city sourcing to contract system
Admissions criteria A minimum of credits completed in any YC SCW undergraduate major with a minimum GPA of and a minimum grade of B in the prerequisite coursework listed below
In addition he oversaw the development of an Enterprise Data Warehouse Business Intelligence system a project that consolidated citywide procurement and contracting legacy systems into a centralized warehouse while leveraging a cloud based infrastructure
For more information visit www yu edu pathways Internships and STEM OPT Gain industry experience in major companies startups and the YU Innovation Lab through internships that count toward your degree
Brian Malkin EDUCATION
Recent Internships Merck Kantar Health BioMarin Marwood Group New York Stem Cell Foundation Lucerna SFA Therapeutics Interested in this program
Biochemistry BIOGRAPHY Brian Malkin is an instructor in the M in Biotechnology Management and Entrepreneurship program and a partner at the law firm of McDermott Will Emery in Washington D C
Brandon Chiazza Brandon Chiazza a DAV instructor and chief technology officer in the New York City Mayor Office of Contract Services leads a team of independent consultants and directs employees in three units Enterprise Data Services Project Management Office and Design and Quality Assurance in the technology strategy division
His practice which is at the intersection of FDA regulated products and patent law involves partnering with drug manufacturers biotechnology clients medical device companies and cannabis companies as they develop new products and protect their innovations though lifecycle management bringing their products to market and pursuing transactional opportunities
The million PASSPort project an end to end cloud based procurement solution for the City of New York supports approximately transactions and billion in spending annually
He is a key advisor to pharmaceutical and biologic clients in the pre market regulatory review marketing enforcement and lifecycle management phases of product development
Chiazza teaches the course Information Architecture and holds an MPA in environmental and energy economics and environmental finance and a B in communication applied economics and management from Cornell University
At the Katz School he teaches the course Intellectual Property Regulation and Compliance for Biotechnology Companies
The George Washington University B A Economics Minor Political Science Cum Laude with Special Honors in Economics The George Washington University Law School J D Editor in Chief The Advocate Administrative Advocacy Clinic University of Maryland College Park B
PUBLICATIONS Companies Marketing CBD Products Be Warned FDA Is Watching Law December New FDA Rules Put Onus On Doctors To Curb Opioid Abuse Law March Biosimilars patent litigation in the EU and the US a comparative strategic overview Generics and Biosimilars Initiative GaBI Journal Volume Issue Food Drug Cosmetic Section Profile Section helps food and drug law attorneys explore FDA guidance legislation with a New York State Bar News New York State Bar Association November December Biosimilars patent litigation in the EU and the US a comparative strategic overview GaBI Journal August The FDA Ever Broadening Regulatory Oversight Creates Need for Increased and More
He counsels pharmaceutical and biologic clients on Food and Drug Administration regulatory matters and intellectual property law with an emphasis on patent litigation
Recent Developments in Food and Drug Law Edition Aspatore Thompson Reuters December Will the FDA Provide More Guidance or Manage the Process to Share Risk Evaluation and Mitigation Strategies REMS Financier Worldwide October Free Speech and Off Label Drug Promotion Should Recent Cases Change Your Business Practices Navigating Recent Off Label Promotion Developments Understanding Government Relations and the Potential Impact of Noteworthy Cases Aspatore Special Report Aspatore Thompson Reuters September Co author The Drug Biologics Approval Process An FDLI Primer Food and Drug Law Institute Update Magazine January Challenges to the Development of a Biosimilars Industry in the United States Aspatore Thompson Reuters Recent Developments in Food and Drug Law Edition December Co author Should FDA Understake More Than a Ministerial Role with Respect to Patent Information Food and Drug Law Institute Policy Forum February Co author Disentangling Biobetters under the Biologics Price Competition and Innovation Act of Food and Drug Law Institute Update Magazine February Co author Biosimilars Are a Reality Key Feautres of the Biologics Price Competition and Innovation Act Food and Drug Law Institute Update Magazine June The Letter of the Law How FDA Regulation Will Impact Your Business Tobacco Reporter August Cannabis Law Update Summer Bridging the Gap NYC New York State Bar Association August Speaker Balancing Unity and Individuality
His regulatory experience includes all types of FDA regulated products drugs and biologics including animal drugs and biologics medical devices cannabis foods and dietary supplements cosmetics and tobacco products
ACI Advanced Summit on Medical Device Patents March Host Moderator Reciprocity Issues for New York Admitted Lawyers NYSBA Holiday Networking Event December Moderator Executive Roundtable Life Sciences Industry Update and Business and Legal Issues for Early Stage Companies th Annual Pharmaceutical and Medical Device Conference November Moderator Deconstructing the New Guidance on Expanded Access and Update on Legal Developments Expanded Access FDA New Regulatory Process How Compassionate Use Fits into Proposed Reforms October Speaker Animal Biologic Development The Continuing Debate Between Cure and Cost and Revisiting the Animal Drug Compounding Debate ACI nd Annual Legal Regulatory and Compliance Forum on Animal Health Veterinary Drugs Therapeutics and Animal Food September Speaker Develop Strategies to Successfully Implement the New Guidance Determine Potential Compliance Obstacles and Financial Penalties to Avoid Unanticipated Delays The Pharmacovigilance Finale Rule Summit on IND Safety Reporting August Speaker High Risk Devices Parsing the Premarket Approval Process PMA and Quality System Regulation ACI th Annual FDA Boot Camp July Speaker Amarin FDLI Annual Conference May Speaker Danish Biotech Conference April Speaker The Impact of the Evolving US Biosimilar Regulatory Policies on Bringing Biosimilars to Market CBI th Summit on Biosimilars January Moderator FDA Update Recent Developments and New Initiatives Including a MDUFA Update and Off Label Promotion in the Wake of the Amarin Decision th Annual Medical Device and Life Sciences Conference November Moderator Amarin and the Future of Off Label Promotion FDLI November Panelist Foreign Corrupt Practices Act and Corporate Accountability Pennsylvania Bar Institute st
He holds a J D from George Washington University Law School and a B A in economics and B in biochemistry from George Washington University
Annual Conference September Panelist Drug Compounding in the Animal Drug Industry Assessing Fair and Foul Practices ACI Legal Regulatory and Compliance Forum on Animal Health Veterinary Medicines and Therapeutics September Speaker Develop Strategies to Continue Building Successful Benefit Risk Assessments CBI Benefit Risk Assessment Decision Making Summit August Speaker Protecting Both Innovation and Competition Finding Compromise Within Federal and State Biosimilars Substitution Laws ACI th Annual Summit on Biosimilars June Panelist Breakout Session Center for Drug Evaluation and Research CDER FDLI Annual Conference April Panelist Biosimilars Patent Litigation European Generic Medicines Association EGMA th Legal Affairs Forum March Panelist FDA LDT and IVD
TEACHING AND RESEARCH INTERESTS Mr Malkin frequently speaks and write on numerous FDA and intellectual property law issues including clinical trials and new product development for complex and challenging products such as biotechnology products orphan drugs generic drugs b new drug applications patent term restoration under the Hatch Waxman Act biosimilar products tobacco products patent term adjustment risk management and due diligence
Career Opportunities in Food Drug Law FDLI Annual Conference April Guest Speaker Safety v Competition Federal Trade Commission Follow On Biologics Workshop Impact of Recent Legislative and Regulatory Naming Proposals on Competition February Overview BioCentury
User Fees How Will This Affect Enforcement the Increasing Need for Sponsor Self Regulation and the FDA Regulatory Priorities
He counsels pharmaceutical and biologic clients on Food and Drug Administration regulatory matters and intellectual property law with an emphasis on patent litigation
Leadership Skills for Managing Culturally Divergent Clinical Teams DIA Global Annual Meeting Boston MA Speaker Launch an Expanded Access Program That Effectively Supports Patient Needs and Compliantly Enhances Drug Development World Congress Life Sciences Market Access Oncology Summit February Philadelphia PA Moderator Embracing the Continuum of Risk CTP Builds Policy on Product Standards and Tobacco Flavoring and Reassesses Regulatory Priorities in Aftermath of the Deeming Rule NYSBA Food Drug Cosmetic Law Section Meeting January New York NY Guest Lecturer Health Law and Regulation LAWG LAWJ Fall Georgetown Law School October Speaker Violations Enforcement and International Issues FDLI Introduction to U Biologics and Biosimilars Law and Regulation October Panelist US Roundtable Discussion and Explore How the New Trump Administration Affects the Future of Pre Approval IQPC Pre Approval Access Programs September Speaker Quality Systems Regulation ACI Fifth Annual FDA Boot Camp Devices Edition July Moderator The Animal Drug Compounding Debate FDLI Annual Conference May Speaker Wearable Health Trackers FDA General Wellness Classification and Patent Protection Oh My
His regulatory experience includes all types of FDA regulated products drugs and biologics including animal drugs and biologics medical devices cannabis foods and dietary supplements cosmetics and tobacco products
Annual Meeting November Speaker Developments in Global Intellectual Property International Generic Pharmaceutical Alliance IGPA th
He holds a J D from George Washington University Law School and a B A in economics and B in biochemistry from George Washington University
The ABC of Clinical Lab Test Development New York State Bar Association Food Drug and Cosmetic Law Section Annual Meeting January Panelist Analyze the FDA Newly Released REMS Standardization Report and Highlight Key Consideration to Collaborate Successfully in a Single Shared REMS ExL Pharma th Risk Evaluation and Mitigation Strategies Summit January Speaker Insights into Developing the Best Regulatory Pathway for Your Venture and Methods of Designing an Efficient and Productive Clinical Trial Climbing the Regulatory Summit December Speaker FDA Update Recent Developments and New Initiatives th Annual Medical Device and Life Sciences Conference November Co Speaker Regulations The Good the Bad and the Ugly Food Safety Challenges in an Era of Change How to Better Protect Your Food and Beverage Company Your Customers and Yourself October Moderator Issues Concerning Development of Rare Disease and Special Population Medical Devices AdvaMed The MedTech Conference October Panelist The Case for Small Markets with Large Returns Orphans Rare Disease Panel Life Science Nation Redefining Early Stage Investments September Panelist Pre Conference Primer Biosimilars Comprehensive Deep Dive into the Relevant Legal Regulatory and Scientific Factors Companies Must Know ACI th Annual Conference on Biosimilars June Speaker Breakfast Breakout
Brittany Palmer M CCC SLP EXPERTISE
This Week February Speaker Biotechnology Roundtable Innovative Strategies for New Product Development Montgomery County Department of Economic Development February Speaker FDA Regulation The Intersection of Policy and Politics The Opportunities and Challenges for Innovation Perspectives from Two Former FDEA Officials New York State Bar Association Food Drug and Cosmetic Law Section Annual Meeting January Speaker Understand the FDA Report Risk Evaluation and Mitigation Strategies REMS Standardization and the Impact on the Industry ExL Pharma th Risk Evaluation and Mitigation Strategies Summit January EMAIL brian malkin yu edu Brian Malkin J D EXPERTISE Food and Drug Law Intellectual Property Law Attorney Malkin is an instructor in the biotechnology master program and a partner at the law firm of McDermott Will Emery in Washington D C
Lessac Madsen Resonant Voice Therapy Lee Silverman Voice Treatment Brittany Palmer a clinical assistant professor clinical supervisor and CCC SLP specializes in voice disorders and is trained in laryngeal massage Lessac Madsen Resonant Voice Therapy and the Lee Silverman Voice Treatment
His practice which is at the intersection of FDA regulated products and patent law involves partnering with drug manufacturers biotechnology clients medical device companies and cannabis companies as they develop new products and protect their innovations though lifecycle management bringing their products to market and pursuing transactional opportunities
She has significant experience as a clinician in a private practice setting where she has evaluated and treated a wide variety of communication disorders for patients of every age
He is a key advisor to pharmaceutical and biologic clients in the pre market regulatory review marketing enforcement and lifecycle management phases of product development
Burdin Hickok B A EXPERTISE
At the Katz School he teaches the course Intellectual Property Regulation and Compliance for Biotechnology
Cross cultural and crisis management
Voice disorders
He has been an editorial consultant to the Economist Intelligence Unit and a guest contributor on CNBC providing timely insight into the complex political and economic dynamics of the Middle East and the potential for disruptions to the global crude oil markets
Her performance career has featured principal opera roles choral ensemble singing and recital engagements across the country and abroad
The PRTs were civilian led diplomatic outposts that partnered with the U military and Iraqi provincial governments to help create political progress and economic development in support of long term stability for Iraq
She holds an M in speech language pathology from Western Kentucky University and master of music from the Eastman School of Music
He was the spokesperson for U development efforts in Kirkuk and regularly conducted economic briefings at the highest levels for the U government
Institutional fixed income currency and commodities markets
He was director of Fixed Income Research Services for Institutional Investor magazine and co managed the startup of Swiss Bank Corporation government securities sales desk
Burdin Hickok is an international strategic management expert political economist and former U diplomat with a long career in the global financial markets with top tier New York investment banks is an instructor in the Katz School biotechnology program and an adjunct assistant professor of finance economics and international leadership and management at the NYU School of Professional Studies
Hickok holds a B A in political science from Denison University has conducted graduate work in international political economy at the University of Virginia and expects to complete his Doctor of Business Administration ABD at the Fox School of Business Temple University in the spring of
In April he returned from a three year appointment with the Department of State as the economic development section head and senior banking and finance advisor to the government of Iraq for the Kirkuk Provincial Reconstruction Team PRT
Clinical Research Clinical Trials Study Design Management of Clinical Trials Christina Brennan is Northwell Health vice president of clinical research and has more than years of extensive clinical research experience including over years in clinical research management roles
In this contested province he led a whole of government approach toward development including close cooperation with the efforts and professionals of the UN Assistance Mission Iraq UNAMI
Her research interests are focused on carotid artery disease and valvular heart disease and she has published in Contemporary Clinical Trials Communications Journal of the American Heart Association Catheterization and Cardiovascular Interventions and Journal of the American College of Cardiology
He has over years of experience in the fixed income foreign currency and commodities markets
She teaches Clinical Trials and Research Management
During his career in the global capital markets he was an investment strategist and strategic client relationship manager developing portfolio optimization strategies with top New York Investment banks such as Bankers Trust Swiss Bank Corporation Bank of America and Lehman Brothers
With the Katz School master in cybersecurity you ll develop the technological and managerial expertise to plan implement upgrade monitor and audit cybersecurity protocols and procedures
Christina Brennan MBA EXPERTISE
Recent Projects Capture the Flag Opportunities for the Cybersecurity Classroom Two Step Verification System Using Face Recognition Cymple Bits Security Analysis Won st Place in the ISACA Cybersecurity Case Study Competition Equifax Data Breach Analysis Won st Place in the ISACA Cybersecurity Case Study Competition Tech Fellows Join students and alumni from over countries to work on pioneering research citywide initiatives and new technologies that help to make the world smarter safer and healthier
She has authored chapters in textbooks manuscripts abstracts and journal articles and has presented at numerous scientific clinical and research meetings
B A M Pathways Option Through the B A M option undergraduates from Yeshiva College and Stern College for Women can take up to nine graduate credits that will count toward both their bachelor and master degrees
She is a member of the Clinical Trials Transformation Initiative with Duke University and the U Food and Drug Administration where she works on new initiatives as a member of several committees sits on the oncology advisory board and technology site advocacy group with the Society for Clinical Research Sites is a member of both the Women in Bio and the American College of Healthcare Executives and is on the board of trustees for the Association of Clinical Research Professionals where she is the immediate past president of the local New York metropolitan chapter
Admissions criteria Junior or senior in any YC SCW undergraduate major with a minimum GPA of and a minimum grade of B plus in the prerequisite courses listed below
She holds an M D from Windsor University Medical School and an MBA from Hofstra University
Prerequisites for graduate courses
You ll master state of the art technologies and practices and you ll get hands on experience with threat mitigation detection and defense in the heart of New York City a global hub for cybersecurity
For more information visit www yu edu pathways Internships and STEM OPT Gain industry experience in major companies startups and the YU Innovation Lab through internships that count toward your degree
Benefits Receive industry mentorship Showcase and publish your research at Katz School annual Symposium on Science Technology and Health Receive a scholarship reducing total tuition to K for your entire graduate degree start to finish whether you complete your degree in one or two years about the Fellows Program
International students may be eligible for up to months of Optional Practical Training OPT
After completing their bachelor students can finish their graduate degree in just one more year
Recent Internships Radware New York City MTA Bank of New York Mellon Technical Consulting and Research Inc American Eagle Outfitters Interested in this program
Students can begin taking graduate coursework in their junior or senior year
Strategic planning and analysis Daniel Davidson is an instructor in the Katz School biotechnology master program and an expert and leader in operations and transformation functions leading organizations to increased revenues and operational effectiveness
One computer networking or security course with a minimum grade of B plus
He has been the managing principal of Davidson Advisory since where he redesigned operating model and processes for scalability from approximately B B clients to global capacity for several thousand including simplification of UX UI design infrastructure and strategy of AdTech content marketplace
Yeshiva University master in cybersecurity is a STEM approved degree
He holds an MBA in finance and marketing from Columbia University and a B in operations research and industrial engineering from Cornell University
The program also offers several opportunities for Curricular Practical Training CPT
By transforming quantitative data into qualitative insights data analytics professionals shape organizational strategies and impact the bottom line
Â  Daniel Davidson MBA EXPERTISE
Learn from world class professionals and get real world predictive and analytical skills in the heart of New York City
He was an adjunct professor in business and technology management at New York University and an adjunct professor in business management at Mercy College
Benefits Receive industry mentorship Showcase and publish your research at Katz School annual Symposium on Science Technology and Health Receive a scholarship reducing total tuition to K for your entire graduate degree start to finish whether you complete your degree in one or two years about the Fellows Program
Prior to that he was senior vice president of strategy and business management for Citibank where led a team responsible for financial analysis KPI performance metrics design and management business cases and insight studies driving decisions on core strategy and tactics in digital leadership and set digital channel roadmap across countries reducing cost and complexity
After completing their bachelor students can finish their graduate degree in just one more year
Data is the information economy fuel like solar energy it is a renewable resource that can benefit everyone at once without being diminished